Olanzapine and Fluoxetine

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 5, 2026
Approval ID: 3c28cf18-01a3-468a-ab3e-8aa82f918251
Products: 5 registered
Version: 24

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE and FLUOXETINE capsules, for oral useInitial U.S. Approval: 2003

Quick Stats

Total Products5

Labelers2

Label Sections44

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.